Retrospective observational study on the causes of excessive menstrual bleeding

Not yet recruiting

Conditions: Abnormal uterine and vaginal bleeding, unspecified. Ayurveda Condition: ASRUGDARAH/RAKTAPRADARAH,

Registration Number: CTRI/2022/07/044349

Lead Sponsor: National Institute of Ayurveda Deemed to be University Jaipur

Brief Summary: Abnormal uterine bleeding affects 10-30% of reproductive aged woman and up to 50% of peri-menopausal woman. The prevalence ofabnormal uterine bleeding due to DUB was 50.90%, which is more commonly seen in age group 20-40 years. The prevalence of puberty menorrhagia was 8.20% in general and 51% among age group <20 years.Various reports suggest that 30 to 50% of women in the reproductive age group suffer from excessive and irregular uterine bleeding. Among them 28% of the female population having excessive menstruation do not plan their social activities around their menstrual cycle, and nearly 10% of employed women need to take time off work because of excessive menstrual loss; 6 % of women aged 25 to 44 consult their General practitioners about excessive menstrual loss every year. 35 % of these referred to hospital, 60 % will have a hysterectomy in the next 5 years, and over 75000 hysterectomies are now carried out every year with 30 % of them carried out for menstrual disturbances alone.In Ayurveda exact aetiology and risk factors for the development of the disease is identified. This includes diet, dietary habits, lifestyle, psychological factors etc. In the present study an attempt will be made to establish connection between the aetiological/risk factors causing Asrigdara including the so far unidentified factorsin causing the onset of Asirgdara

AIM: To assess the probable etiological factors described under the general and specific aetiology of the Asrigdara in Ayurveda.

OBJECTIVES: To establish the relationship between aetiological factors and disease manifestation

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: Female

Target Recruitment: 100

Inclusion Criteria

Women with PBAC score of â‰¥100 will be recruited in the study.

Exclusion Criteria

Women who are taking or taken contraceptives like OCPs, IUCD.
Women diagnosed with endometrial cancers.
Women with coagulatory defects.

Study & Design

Study Type: Observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Confirmation of causitive factors	One year

Secondary Outcome Measures

Name	Time	Method
Correlate the classical Nidana factors with observed nidana factors	1 year

Trial Locations

Locations (1): Madhav vilas hospital OPD 26 and 27
🇮🇳
Jaipur, RAJASTHAN, India
Madhav vilas hospital OPD 26 and 27
🇮🇳Jaipur, RAJASTHAN, India
Bharathi Kumaramangalam
Principal investigator
9492047131
baruhunt@gmail.com